Quotient Sciences

Arcinova is a contract development and manufacturing organization that provides a range of services to pharmaceutical and biotechnology companies worldwide. The company specializes in the drug development pathway, offering expertise in areas such as drug substance synthesis, manufacturing scale-up, drug product manufacturing, bioanalytical services, and radiolabelling synthesis. Arcinova's innovative and agile approach allows it to effectively tackle project challenges, enabling clients—from established multinationals to emerging start-ups—to bring life-changing medicines to market more rapidly and cost-effectively. By leveraging transformational technology and integrated tools, Arcinova aims to enhance patient care and streamline the drug development process for its partners.

PharMaterials Ltd. is a contract research organization based in Reading, United Kingdom, specializing in the development of preclinical and early-phase drug formulations and the manufacture of clinical trial materials. Founded in 2000, the company focuses on optimizing drug substance physical forms, including salts, polymorphs, and co-crystals. It operates manufacturing suites that provide comprehensive services, including characterization, formulation development, and global supply for clinical trials. PharMaterials Ltd. is a subsidiary of Quotient Clinical Ltd., further enhancing its capabilities in the pharmaceutical development sector.

Founded in 2002, QS Pharma specialises in the formulation development and manufacturing of small molecule drug products, and is capable of supporting customer programs through all stages of development and commercialisation. Of particular relevance is QS Pharma’s capability to work with high potency molecules, which is a fast-growing market need.

SeaView Research, Inc. is a clinical research organization based in Miami, Florida, specializing in clinical pharmacology testing and laboratory services for the pharmaceutical industry. Established in 1995, the company conducts a wide range of studies, including pharmacokinetic and pharmacodynamic assessments, thorough ECG/QTc evaluations, drug interaction studies, and first-in-man trials. SeaView Research also focuses on various therapeutic areas, such as type II diabetes, obesity, dermatology, and cardiovascular conditions, and employs diverse drug administration methods, including oral, topical, and intravenous delivery. The organization is dedicated to upholding high standards of quality and integrity while managing complex clinical research studies, particularly in early Phase I and Phase II trials. SeaView Research operates as a subsidiary of Quotient Clinical Ltd.